Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months

被引：0
|
作者：
Edoardo Caronna
Victor José Gallardo
Alicia Alpuente
Marta Torres-Ferrus
Patricia Pozo-Rosich
机构：
[1] Universitat Autònoma de Barcelona,Neurology Department, Hospital Universitari Vall d’Hebron, Department of Medicine
[2] Universitat Autònoma de Barcelona,Headache and Neurological Pain Research Group, Vall d’Hebron Research Institute, Department of Medicine
来源：
The Journal of Headache and Pain | 2021年 / 22卷
关键词：
Migraine; Medication overuse; CGRP; Monoclonal antibodies; Erenumab; Galcanezumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study
    Torres-Ferrus, Marta
    Gallardo, Victor J.
    Alpuente, Alicia
    Caronna, Edoardo
    Gine-Cipres, Eulalia
    Pozo-Rosich, Patricia
    JOURNAL OF NEUROLOGY, 2021, 268 (10) : 3789 - 3798
  • [22] Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
    Amy R. Tso
    Peter J. Goadsby
    Current Treatment Options in Neurology, 2017, 19
  • [23] Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
    Tso, Amy R.
    Goadsby, Peter J.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2017, 19 (08)
  • [24] Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients
    Albert Muñoz-Vendrell
    Sergio Campoy
    Edoardo Caronna
    Alicia Alpuente
    Marta Torres-Ferrus
    Candela Nieves Castellanos
    Marina Olivier
    Jaume Campdelacreu
    Joan Prat
    Javier Camiña Muñiz
    Francisco José Molina Martínez
    Ane Mínguez-Olaondo
    Marta Ruibal Salgado
    Sonia Santos Lasaosa
    María Pilar Navarro Pérez
    Noemí Morollón
    Alba López Bravo
    Luis Miguel Cano Sánchez
    Sonia María García-Sánchez
    Jésica García-Ull
    Laura Rubio-Flores
    Alicia Gonzalez-Martinez
    Sonia Quintas
    Ana Echavarría Íñiguez
    Sendoa Gil Luque
    María Victoria Castro-Sánchez
    Vanesa Adell Ortega
    Jessica García Alhama
    Nuria Berrocal-Izquierdo
    Robert Belvís
    Samuel Díaz-Insa
    Patricia Pozo-Rosich
    Mariano Huerta-Villanueva
    The Journal of Headache and Pain, 24
  • [25] Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients
    Munoz-Vendrell, Albert
    Campoy, Sergio
    Caronna, Edoardo
    Alpuente, Alicia
    Torres-Ferrus, Marta
    Nieves Castellanos, Candela
    Olivier, Marina
    Campdelacreu, Jaume
    Prat, Joan
    Camina Muniz, Javier
    Molina Martinez, Francisco Jose
    Minguez-Olaondo, Ane
    Ruibal Salgado, Marta
    Santos Lasaosa, Sonia
    Navarro Perez, Maria Pilar
    Morollon, Noemi
    Lopez Bravo, Alba
    Cano Sanchez, Luis Miguel
    Garcia-Sanchez, Sonia Maria
    Garcia-Ull, Jesica
    Rubio-Flores, Laura
    Gonzalez-Martinez, Alicia
    Quintas, Sonia
    Echavarria Iniguez, Ana
    Gil Luque, Sendoa
    Castro-Sanchez, Maria Victoria
    Adell Ortega, Vanesa
    Garcia Alhama, Jessica
    Berrocal-Izquierdo, Nuria
    Belvis, Robert
    Diaz-Insa, Samuel
    Pozo-Rosich, Patricia
    Huerta-Villanueva, Mariano
    JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01)
  • [26] Anti-CGRP monoclonal antibodies: breakthrough in migraine therapeutics
    Krishnaswamy, Ratna
    Malik, Bilal Haider
    Khan, Safeera
    Gupta, Deepti
    Islam, Muhammad
    Mandel, Shrawan Kumar
    Rutkofsky, Ian H.
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2019, 23 (03) : 26 - 33
  • [27] Anti-CGRP and Anti-CGRP Receptor Monoclonal Antibodies for Migraine Prophylaxis: Retrospective Observational Study on 209 Patients
    Schweiger, Vittorio
    Bellamoli, Paola
    Taus, Francesco
    Gottin, Leonardo
    Martini, Alvise
    Nizzero, Marta
    Bonora, Eleonora
    Del Balzo, Giovanna
    Donadello, Katia
    Secchettin, Erica
    Finco, Gabriele
    De Santis, Daniele
    Polati, Enrico
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (04)
  • [28] Patient selection for migraine preventive treatment with anti-CGRP(r) monoclonal antibodies
    Negro, Andrea
    Martelletti, Paolo
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (08) : 769 - 776
  • [29] Effectiveness of anti-CGRP monoclonal antibodies in the preventive treatment of migraine: A prospective study of 63 patients
    Castrillo, Ana
    Mendoza, Amelia
    Caballero, Lorena
    Cerdan, Debora
    Rodriguez, Maria Fernanda
    Guerrero, Pilar
    Tabernero, Cesar
    Ferrero, Marta
    Benito, Ines
    Marin, Laura
    Duarte, Jacinto
    MEDICINA CLINICA, 2023, 160 (08): : 341 - 346
  • [30] Potential Predictors of Response to CGRP Monoclonal Antibodies in Chronic Migraine: Real-World Data
    Sanchez-Rodriguez, Carmen
    Gago-Veiga, Ana Beatriz
    Garcia-Azorin, David
    Guerrero-Peral, Angel Luis
    Gonzalez-Martinez, Alicia
    CURRENT PAIN AND HEADACHE REPORTS, 2024, 28 (12) : 1265 - 1272
12345